Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Future Science OA|August 18, 2020
The safety of a therapeutic product composed of a combination of stem cell released molecules from adipose mesenchymal stem cells and fibroblastsGreg Maguire, Peter FriedmanWorld Journal of Stem Cells|June 2, 2015
Systems biology approach to developing S(2)RM-based "systems therapeutics" and naturally induced pluripotent stem cellsGreg Maguire, Peter FriedmanBiomedical Reports|March 21, 2014
Enhancing spontaneous stem cell healing (Review)Greg Maguire, Peter FriedmanHuman Vaccines & Immunotherapeutics|March 4, 2022
Using a "systems therapeutic for physiological renormalization" approach to vaccine development. Covid-19 as an exampleGreg MaguireThe Journal of Clinical and Aesthetic Dermatology|September 19, 2019
The Safe and Efficacious Use of Secretome From Fibroblasts and Adipose-derived (but not Bone Marrow-derived) Mesenchymal Stem Cells for Skin TherapeuticsGreg MaguireACS Medicinal Chemistry Letters|June 6, 2014
Systems biology approach to developing "systems therapeutics"Greg MaguireCommunicative & Integrative Biology|September 16, 2021
Stem cells part of the innate and adaptive immune systems as a therapeutic for Covid-19Greg MaguireWorld Journal of Stem Cells|January 10, 2018
Amyotrophic lateral sclerosis as a protein level, non-genomic disease: Therapy with S2RM exosome released moleculesGreg MaguireJournal of Tissue Viability|September 17, 2022
Chronic inflammation induced by microneedling and the use of bone marrow stem cell cytokinesGreg MaguireExpert Review of Molecular Diagnostics|October 22, 2013
Using a systems-based approach to overcome reductionist strategies in the development of diagnosticsGreg MaguirePageof 3